Abstract |
The activities of linezolid, eperezolid, and PNU-100480 were evaluated in a murine model of tuberculosis. Approximately 10(7) viable Mycobacterium tuberculosis ATCC 35801 organisms were given intravenously to 4-week-old outbred CD-1 mice. In the first study, treatment was started 1 day postinfection and was given by gavage for 4 weeks. Viable cell counts were determined from homogenates of spleens and lungs. PNU-100480 was as active as isoniazid. Linezolid was somewhat less active than PNU-100480 and isoniazid. Eperezolid had little activity in this model. In the next two studies, treatment was started 1 week postinfection. A dose-response study was performed with PNU-100480 and linezolid (both at 25, 50, and 100 mg/kg of body weight). PNU-100480 was more active than linezolid, and its efficacy increased with an escalation of the dose. Subsequently, the activity of PNU-100480 alone and in combination with rifampin or isoniazid was evaluated and was compared to that of isoniazid- rifampin. The activity of PNU-100480 was similar to that of isoniazid and/or rifampin in the various combinations tested. Further evaluation of these oxazolidinones in the murine test system would be useful prior to the development of clinical studies with humans.
|
Authors | M H Cynamon, S P Klemens, C A Sharpe, S Chase |
Journal | Antimicrobial agents and chemotherapy
(Antimicrob Agents Chemother)
Vol. 43
Issue 5
Pg. 1189-91
(May 1999)
ISSN: 0066-4804 [Print] United States |
PMID | 10223934
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acetamides
- Anti-Bacterial Agents
- Antitubercular Agents
- Oxazoles
- Oxazolidinones
- U 100480
- eperezolid
- Linezolid
|
Topics |
- Acetamides
(pharmacology, therapeutic use)
- Animals
- Anti-Bacterial Agents
(pharmacology, therapeutic use)
- Antitubercular Agents
(pharmacology, therapeutic use)
- Female
- Linezolid
- Mice
- Mycobacterium tuberculosis
(drug effects)
- Oxazoles
(pharmacology, therapeutic use)
- Oxazolidinones
- Tuberculosis
(drug therapy)
|